DNIB0600A
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for DNIB0600A, covering 2017-06-07 to 2017-08-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study of DNIB0600A in Comparison With Pegylated Liposomal Doxorubicin (PLD) in Participants With Platinum-Resistant Ovarian Cancer (PROC) [Phase 2]